New approach could improve accuracy of liquid biopsy tests

FHS
July 4, 2023
2:54 am

A research team led by Xianghong Jasmine Zhou, PhD, professor of Pathology and Laboratory Medicine at the David Geffen School of Medicine at UCLA, has made an important advancement to address one of the major challenges in cell-free DNA (cfDNA) testing, also known as liquid biopsy.

Adaptive trial designs will increase clinical trial speed, safety, and effectiveness

Health care is undergoing an important and well-needed shift from a one-size-fits-all approach to more personalized, precise, patient-focused care. A similar approach needs to be

July 12, 2024

Mersana slapped with partial FDA hold after five patient deaths in ovarian cancer studies

Another one of Mersana’s clinical programs is reporting patient deaths in a study, and now it’s prompting the FDA to step in. The agency slapped

June 15, 2023

Pharmalittle: We’re reading about AstraZeneca threatening the U.K., mpox vaccine distribution, and more

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal

August 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.